Company / Free Cash Flow per Share
BridgeBio Pharma, Inc. Free Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.35
FY2025
5-year range
-$3.39 / -$2.09
FY2021-FY2025
Trend
+21.1%
vs FY2024
Sector context
#139 of 192
Health Care
What the data says
At $-2.35, BridgeBio Pharma, Inc.'s free cash flow per share ranks #139 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 9 years, ranging from $-3.39 in FY2023 to $-1.34 in FY2017.
Based on SEC 10-K filings.
-2.35 in FY2025.
Improved from $-3.39 to $-2.35 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#139 of 192 in Health CareTop 72% of 192This company -$2.35 Sector average $3.32
▼
-170.9% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 21.1% year-over-year.
- Ranks #139 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2017.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.35 | +21.1% |
| FY2024 | -$2.98 | +12.2% |
| FY2023 | -$3.39 | -17.8% |
| FY2022 | -$2.88 | -38.1% |
| FY2021 | -$2.09 | +36.7% |
| FY2020 | -$3.29 | -18.3% |
| FY2019 | -$2.78 | -23.8% |
| FY2018 | -$2.25 | -67.9% |
| FY2017 | -$1.34 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026